Diarrhea as a postoperative complication of surgically treated retroperitoneal neurogenic tumors in children

Abstract

BACKGROUND: Diarrhea as a result of skeletonization of the superior mesenteric artery (SMA) and celiac trunk after retroperitoneal lymph node dissection is a common complication in adult patients with malignant neoplasms of the pancreas, colon, and retroperitoneal tumors. The reports mentioning this complication in the treatment of neurogenic tumors in children are scarce.

AIM: This study aims to improve the surgical treatment results of locally advanced retroperitoneal neuroblastomas by studying which factors influence the development of prolonged postoperative diarrhea.

MATERIALS AND METHODS: An analysis of the treatment results in patients with locally advanced neurogenic retroperitoneal neoplasms at the Dmitry Rogachev national medical research center of pediatric hematology, oncology, and immunology from 2018 to 2020 was conducted. All patients from this cohort underwent SMA and celiac trunk dissection.

RESULTS: During this period, surgeries with dissection of the SMA and celiac trunk were performed in 29 patients. In four (13%) cases, prolonged diarrhea was noted (median duration, 136.5 days with a frequency of up to 13 times a day). Assessment of the dependence of diarrhea frequency on complete dissection or preservation of the tumor component in the SMA and celiac trunk showed no significant differences.

CONCLUSIONS: The complete removal of a neurogenic tumor improves prognosis in patients with a locally advanced form of the disease, but it is associated with the risk of long-term intractable complications. This study does not confirm the opinion that preservation of the tumor component on the SMA prevents its denervation and postoperative diarrhea.

Keywords

neurogenic tumor / retroperitoneal lymph node dissection / diarrhea / dissection of the superior mesenteric artery / children

References

[1] Fischer J, Pohl A, Volland R, et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17(1):520. DOI: 10.1186/s12885-017-3493-0

[2] Fischer J., Pohl A., Volland R., et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months // BMC cancer. 2017. Vol. 17, No. 1. P. 520–528. DOI: 10.1186/s12885-017-3493-0

[3] Yeung F, Chung PY, Tam PH, Wong KY. Is complete resection of high-risk stage IV neuroblastoma associated with better survival? J Pediatr Surg. 2015;50(12):2107–2111. DOI: 10.1016/j.jpedsurg.2015.08.038

[4] Yeung F., Chung P.Y., Tam P.H., Wong K.Y. Is complete resection of high-risk stage IV neuroblastoma associated with better survival? // J Pediatr Surg. 2015. Vol. 50, No. 12. P. 2107–2111. DOI: 10.1016/j.jpedsurg.2015.08.038

[5] Allmen DV, Davidoff AM, London WB, et al. Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. J Clin Oncol. 2017;35(2):1–11. DOI: 10.1200/JCO.2016.67.2642

[6] Allmen D.V., Davidoff A.M., London W.B., et al. Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma // J Clin Oncol. 2017. Vol. 35, No. 2. P. 1–11. DOI: 10.1200/JCO.2016.67.2642

[7] Adkins ES, Sawin R, Gerbing RB, et al. Efficacy of Complete Resection for High-Risk Neuroblastoma: A Children’s Cancer Group Study. J Pediatr Surg. 2004;39(6):931–936. DOI: 10.1016/j.jpedsurg.2004.02.041

[8] Adkins E.S., Sawin R., Gerbing R.B., et al. Efficacy of Complete Resection for High-Risk Neuroblastoma: A Children’s Cancer Group Study // J Pediatr Surg. 2004. Vol 39, No 6. P. 931–936. DOI: 10.1016/j.jpedsurg.2004.02.041

[9] Kiely EM. The Surgical Challenge of Neuroblastoma. J Pediatr Surg. 1994;29(2):128–133. DOI: 10.1016/0022-3468(94)90307-7

[10] Kiely E.M. The Surgical Challenge of Neuroblastoma // J Pediatr Surg. 1994. Vol. 29, No. 2. P. 128–133. DOI: 10.1016/0022-3468(94)90307-7

[11] Thorsen Y, Stimec B, Andersen SN, et al. Bowel function and quality of life after superior mesenteric nerve plexus transection in right colectomy with D3 extended mesenterectomy. Tech Coloproctol. 2016;20(7):445–453. DOI: 10.1007/s10151-016-1466-y

[12] Thorsen Y., Stimec B., Andersen S.N., et al. Bowel function and quality of life after superior mesenteric nerve plexus transection in right colectomy with D3 extended mesenterectomy // Tech Coloproctol. 2016. Vol. 20, No. 7. P. 445–453. DOI: 10.1007/s10151-016-1466-y

[13] Tokiwa K, Fumino S, Ono S, Iwai N. Results of Retroperitoneal Lymphadenectomy in the Treatment of Abdominal Neuroblastoma. Arch Surg. 2003;138(7):711–715. DOI: 10.1001/archsurg.138.7.711

[14] Tokiwa K., Fumino S., Ono S., Iwai N. Results of Retroperitoneal Lymphadenectomy in the Treatment of Abdominal Neuroblastoma // Arch Surg. 2003. Vol. 138. P. 711–715. DOI: 10.1001/archsurg.138.7.711

[15] Egorov VI, Melekhina OV, Vishnevsky VA, Shevchenko TV. Remote results and prognosis in pancreatic head ductal cancer patients after standard and extended pancreatectomy. Annals of Surgical Hepatology. 2009;15(1):62–73. (In Russ.)

[16] Егоров В.И., Мелехина О.В., Вишневский В.А., Шевченко Т.В. Отдаленные результаты и прогноз протоковой аденокарциномы головки поджелудочной железы после стандартной и расширенной панкреатодуоденальной резекции // Анналы хирургической гепатологии. 2009. Т. 15, № 1. С. 62–73.

[17] Nimura Y., Nagino M., Takao S., et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas. J Hepatobiliary Pancreat Sci. 2012;19(3):230–241. DOI: 10.1007/s00534-011-0466-6

[18] Nimura Y., Nagino M., Takao S., et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas // J Hepatobiliary Pancreat Sci. 2012. Vol. 19, No. 3. P. 230–241. DOI: 10.1007/s00534-011-0466-6

[19] Rees H, Markley MA, Kiely EM, et al. Diarrhea after resection of advanced abdominal neuroblastoma: A common management problem. Surgery. 1998;123(5):568–572.

[20] Rees H., Markley M.A., Kiely E.M., et al. Diarrhea after resection of advanced abdominal neuroblastoma: A common management problem // Surgery. 1998. Vol. 123, No. 5. P. 568–572.

[21] Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. DOI: 10.1097/01.sla.0000133083.54934.ae

[22] Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey // Ann Surg. 2004. Vol. 240, No. 2. P. 205–213. DOI: 10.1097/01.sla.0000133083.54934.ae

[23] Kettenmann H. Nervous System. In: Gray’s Anatomy. The Anatomical Basis of Clinical Practise. 41st Edition. Standring S., editor-in-chief. Elsevier. 2016. Р. 42–67.

[24] Kettenmann H. Nervous System. In: Gray’s Anatomy. The Anatomical Basis of Clinical Practise. 41st Edition. Standring S., editor-in-chief. Elsevier. 2016. P. 42–67.

[25] Nagakawa Y, Yi ShQ, Takishita Ch, et al. Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2020;27(6):342–351. DOI: 10.1002/jhbp.725

[26] Nagakawa Y., Yi Sh.Q., Takishita Ch., et al. Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer // J Hepatobiliary Pancreat Sci. 2020. Vol. 27, No. 6. P. 342–351. DOI: 10.1002/jhbp.725

[27] Takahashi H, Ohigashi H, Ishikawa O, et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg. 2012;255(1):95–102. DOI: 10.1097/SLA.0b013e31823d813c

[28] Takahashi H., Ohigashi H., Ishikawa O., et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer // Ann Surg. 2012. Vol. 255, No. 1. P. 95–102. DOI: 10.1097/SLA.0b013e31823d813c

[29] Chen JW, Bhandari M, Astill DS, et al. Predicting patient survival after pancreaticoduodenectomy for malignancy: Histopathological criteria based on perineural infiltration and lymphovascular invasion. Hpb. 2010;12(2):101–108. DOI: 10.1111/j.1477-2574.2009.00140.x

[30] Chen J.W., Bhandari M., Astill D.S., et al. Predicting patient survival after pancreaticoduodenectomy for malignancy: Histopathological criteria based on perineural infiltration and lymphovascular invasion // Hpb. 2010. Vol. 12, No. 2. P. 101–108. DOI: 10.1111/j.1477-2574.2009.00140.x

[31] Farnell MB, Aranha GV, Nimura Y, Michelassi F. The Role of Extended Lymphadenectomy for Adenocarcinoma of the Head of the Pancreas : Strength of the Evidence. J Gastrointest Surg. 2008;12(4):651–656. DOI:10.1007/s11605-007-0451-1

[32] Farnell M.B., Aranha G.V., Nimura Y., Michelassi F. The Role of Extended Lymphadenectomy for Adenocarcinoma of the Head of the Pancreas : Strength of the Evidence // J Gastrointest Surg. 2008. Vol. 12, No. 4. P. 651–656. DOI: 10.1007/s11605-007-0451-1

[33] Kotelnikov AG, Abgaryan MG, Zabezhinskii DA, et al. Pancreatic head cancer: current treatment and future prospects. Bulletin of Surgical Gastroenterology. 2007;(3):5–16. (In Russ.)

[34] Котельников А.Г., Абгарян М.Г., Забежинский Д.А., и др. Рак головки поджелудочной железы: современное лечение и дальнейшие перспективы // Вестник хирургической гастроэнтерологии. 2007. № 3. С. 5–16.

[35] Weitz J, Rahbari N, Koch M, Büchler MW. The “Artery First” Approach for Resection of Pancreatic Head Cancer. J Am Coll Surg. 2010;210(2):e1–e4 DOI: 10.1016/j.jamcollsurg.2009.10.019

[36] Weitz J., Rahbari N., Koch M., Büchler M.W. The “Artery First” Approach for Resection of Pancreatic Head Cancer // J Am Coll Surg. 2010. Vol. 210, No. 2. P. e1–e4 DOI: 10.1016/j.jamcollsurg.2009.10.019

[37] Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Ann Surg. 1998;228(4):508–517. DOI: 10.1097/00000658-199810000-00007

[38] Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study // Ann Surg. 1998. Vol. 228, No. 4. P. 508–517. DOI: 10.1097/00000658-199810000-00007

[39] Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–630. DOI: 10.1016/j.surg.2005.06.044

[40] Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma // Surgery. 2005. Vol. 138, No. 4. P. 618–630. DOI: 10.1016/j.surg.2005.06.044

[41] Jang J, Kang MJ, Heo JS, et al. A Prspective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection , Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head Cancer. Ann Surg. 2014;259(4):656–664. DOI: 10.1097/SLA.0000000000000384

[42] Jang J., Kang M.J., Heo J.S., et al. A Prspective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection , Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head Cancer // Ann Surg. 2014. Vol. 259, No. 4. P. 656–664. DOI:10.1097/SLA.0000000000000384

[43] Patent RU No. 2615277 C1. 08.04.2016. Voskanyan SE, Najdenov EV, Korsakov IN. Intestinal reinnervation method during extended lymphadenectomy and neurodissection of intestinal mesentery root. Available from: https://patenton.ru/patent/RU2615277C1 (In Russ.)

[44] Патент РФ на изобретение RU 2 615 277 C1. / 08.04.2016. Воскаян С.Э., Найденов Е.В., Корсаков И.Н. Способ реиннервации тонкой кишки при расширенной лимфаденэктомии и нейродиссекции корня брыжейки тонкой кишки. Режим доступа: https://patenton.ru/patent/RU2615277C1. Дата обращения: 20.05.2021.

[45] Inoue Y, Saiura A, Oba A, et al. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. J Gastrointest Surg. 2019;23(7):1373–1383. DOI: 10.1007/s11605-018-3995-3

[46] Inoue Y., Saiura A., Oba A., et al. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety // J Gastrointest Surg. 2019. Vol. 23, No. 7. P. 1373–1383. DOI: 10.1007/s11605-018-3995-3

[47] Zagaynov VE, Kuchin DM, Gorokhov GG, et al. Ways to improve the results of surgical treatment of adenocarcinoma of the pancreatic head (the Center experience). Clin Experiment Surg Petrovsky J. 2013;(1):23–29. (In Russ.)

[48] Загайнов В.Е., Кучин Д.М., Горохов Г.Г., и др. Пути улучшения результатов хирургического лечения аденокарциномы головки поджелудочной железы (опыт одного центра) // Журнал имени академика Б.В. Петровского. 2013. № 1. С. 23–29.

[49] Patyutko YuI, Kotelnikov AG, Polyakov AN, Podluzhnyi D.V. Evolution of surgery for pancreatic head and periampullary cancer. Annals of HPB surgery. 2019;24(3):45–53. (In Russ.) DOI: 10.16931/1995-5464.2019345-53

[50] Патютко Ю.И., Котельников А.Г., Поляков А.Н., Подлужный Д.В. Эволюция хирургии рака головки поджелудочной железы и периампулярной зоны // Анналы хирургической гепатологии. 2019. Т. 24, № 3. С. 45–53. DOI: 10.16931/1995-5464.2019345-53

[51] Berthold F, Schweinitz D, Bongartz R, et al.; Dept. Pediatric oncology and hematology; Children’s hospital, University of Cologne. NB2004 Trial Protocol for risk adapted treatment of children with neuroblastoma. Köln, Germany. 2014. Chapter 14.8. P. 94–97.

[52] Berthold F., Schweinitz D., Bongartz R., et al.; Dept. Pediatric Oncology and Hematology; Children’s Hospital, University of Cologne. NB2004 Trial Protocol for risk adapted treatment of children with neuroblastoma. Köln, Germany. 2004. Chapter 14.8. P. 94–97.

[53] Simon T, Haberle B, Hero B, et al. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31(6):752–758. DOI: 10.1200/JCO.2012.45.9339

[54] Simon T., Haberle B., Hero B., et al. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis // J Clin Oncol. 2013. Vol. 31, No. 6. P. 752–758. DOI: 10.1200/JCO.2012.45.9339

[55] Holmes K, Pötschger U, Pearson ADJ, et al. Influence of Surgical Excision on the Survival of Patients with Stage 4 High-Risk Neuroblastoma: A Report from the HR-NBL1/SIOPEN Study. J Clin Oncol. 2020;38(25):2902–2915. DOI: 10.1200/JCO.19.03117.

[56] Holmes K., Pötschger U., Pearson A.D.J, et al. Influence of Surgical Excision on the Survival of Patients with Stage 4 High-Risk Neuroblastoma: A Report from the HR-NBL1/SIOPEN Study // J Clin Oncol. 2020. Vol. 38, No. 25. P. 2902–2915. DOI: 10.1200/JCO.19.03117.

RIGHTS & PERMISSIONS

Tverdov I.V., Akhaladze D.G., Kachanov D.Y., Merkulov N.N., Uskova N.G., Rabaev G.S., Grachev N.S.